Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru



ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Лечебное дело
2022 / N 1

Интервенционное лечение фибрилляции предсердий у пациентов с сердечной недостаточностью: за и против
Д.Ф. Ардус, Т.М. Ускач, О.В. Сапельников, С.Н. Терещенко, Р.С. Акчурин

Список литературы

1. Odutayo A, Wong CX, Hsiao AJ, Hopewell S, Altman DG, Emdin CA. Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: systematic review and meta-analysis. BMJ. 2016;354:i4482. DOI: 10.1136/bmj.i4482
2. Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, Seshadri S, Wolf PA, Vasan RS, Benjamin EJ, Levy D. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. The Lancet. 2015;386(9989):154-162. DOI: 10.1016/S0140-6736(14)61774-8
3. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, Nichol G, Pham M, Piña IL, Trogdon JG; American Heart Association Advocacy Coordinating Committee; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Stroke Council. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circulation. Heart Failure. 2013;6(3):606-619. DOI: 10.1161/HHF.0b013e318291329a
4. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. The American Journal of Cardiology. 2003;91(6A):2D-8D. DOI: 10.1016/s0002-9149(02)03373-8
5. Chiang CE, Naditch-Brule L, Murin J, Goethals M, Inoue H, O’Neill J, Silva-Cardoso J, Zharinov O, Gamra H, Alam S, Ponikowski P, Lewalter T, Rosenqvist M, Steg PG. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circulation: Arrhythmia and Electrophysiology. 2012;5(4):632-639. DOI: 10.1161/CIRCEP.112.970749
6. Weber C, Hung J, Hickling S, Nedkoff L, Murray K, Li I, Briffa TG. Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation. Heart (British Cardiac Society). 2021;107(16):1320-1326. DOI: 10.1136/heartjnl-2020-318648
7. Жиров И.В., Сафронова Н.В., Осмоловская Ю.Ф., Терещенко С.Н. Прогностическое значение фибрилляции предсердий у пациентов с сердечной недостаточностью с разной фракцией выброса левого желудочка: результаты многоцентрового регистра РИФ-ХСН. Российский кардиологический журнал. 2021;26(1):44-57. [Zhirov IV, Safronova NV, Osmolovskaya YuF, Тereshchenko SN. Prognostic value of atrial fibrillation in patients with heart failure and different left ventricular ejection fraction: results of the multicenter RIF-CHF register. Russian Journal of Cardiology. 2021;26(1):44-57. (In Russian)]. DOI: 10.15829/1560-4071-2021-4200
8. Trulock KM, Narayan SM, Piccini JP. Rhythm control in heart failure patients with atrial fibrillation: contemporary challenges including the role of ablation. Journal of the American College of Cardiology. 2014;64(7):710-721. DOI: 10.1016/j.jacc.2014.06.1169
9. Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW, Witteman JC, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure The Rotterdam Study. European Heart Journal. 2004;25(18):1614-1619. DOI: 10.1016/j.ehj.2004.06.038
10. Magnussen C, Niiranen TJ, Ojeda FM, Gianfagna F, Blankenberg S, Njølstad I, Vartiainen E, Sans S, Pasterkamp G, Hughes M, Costanzo S, Donati MB, Jousilahti P, Linneberg A, Palosaari T, de Gaetano G, Bobak M, den Ruijter HM, Mathiesen E, Jørgensen T, Söderberg S, Kuulasmaa K, Zeller T, Iacoviello L, Salomaa V, Schnabel RB; BiomarCaRE Consortium. Sex differences and similarities in atrial fibrillation epidemiology, risk factors, and mortality in community cohorts: results from the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe). Circulation. 2017;136(17):1588-1597. DOI: 10.1161/CIRCULATIONAHA.117.028981
11. Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999;100(1): 87-95. DOI: 10.1161/01.cir.100.1.87
12. Sugumar H, Nanayakkara S, Prabhu S, Voskoboinik A, Kaye DM, Ling LH, Kistler PM. Pathophysiology of atrial fibrillation and heart failure: dangerous interactions. Cardiology Clinics. 2019;37(2):131-138. DOI: 10.1016/j.ccl.2019.01.002
13. Gopinathannair R, Etheridge SP, Marchlinski FE, Spinale FG, Lakkireddy D, Olshansky B. Arrhythmia-induced cardiomyopathies: mechanisms, recognition, and management. Journal of the American College of Cardiology. 2015;66(15):1714-1728. DOI: 10.1016/j.jacc.2015.08.038
14. Sramko M, Wichterle D, Melenovsky V, Franekova J, Clemens M, Fukunaga M, Kautzner J. Independent effect of atrial fibrillation on natriuretic peptide release. Clinical Research in Cardiology. 2019;108(2):142-149. DOI: 10.1007/s00392-018-1332-1
15. Chan NY, Seyedi N, Takano K, Levi R. An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition. Circulation. 2012;125(2):298-307. DOI: 10.1161/CIRCULATIONAHA.111.059097
16. Lin YK, Chen YC, Chen YA, Yeh YH, Chen SA, Chen YJ. B-type natriuretic peptide modulates pulmonary vein arrhythmogenesis: a novel potential contributor to the genesis of atrial tachyarrhythmia in heart failure. Journal of Cardiovascular Electrophysiology. 2016;27(12):1462-1471. DOI: 10.1111/jce.13093
17. Roy D, Talajic M, Nattel S, Wyse DG, Dorian P, Lee KL, Bourassa MG, Arnold JM, Buxton AE, Camm AJ, Connolly SJ, Dubuc M, Ducharme A, Guerra PG, Hohnloser SH, Lambert J, Le Heuzey JY, O’Hara G, Pedersen OD, Rouleau JL, Singh BN, Stevenson LW, Stevenson WG, Thibault B, Waldo AL; Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. The New England Journal of Medicine. 2008;358(25):2667-2677. DOI: 10.1056/NEJMoa0708789
18. Lee Park K, Anter E. Atrial fibrillation and heart failure: a review of the intersection of two cardiac epidemics. Journal of Atrial Fibrillation. 2013;6(1):751. DOI: 10.4022/jafib.751
19. Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD; Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. The New England Journal of Medicine. 2002;347(23):1825-1833. DOI: 10.1056/NEJMoa021328
20. Van Gelder IC, Hagens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJ, Tijssen JG, Crijns HJ; Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. The New England Journal of Medicine. 2002;347(23):1834-1840. DOI: 10.1056/NEJMoa021375
21. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL; ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC). Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2021;42(5):373-498. DOI: 10.1093/eurheartj/ehaa612
22. Van Gelder IC, Groenveld HF, Crijns HJ, Tuininga YS, Tijssen JG, Alings AM, Hillege HL, Bergsma-Kadijk JA, Cornel JH, Kamp O, Tukkie R, Bosker HA, Van Veldhuisen DJ, Van den Berg MP; RACE II Investigators. Lenient versus strict rate control in patients with atrial fibrillation. The New England Journal of Medicine. 2010;362(15):1363-1373. DOI: 10.1056/NEJMoa1001337
23. Groenveld HF, Crijns HJ, Van den Berg MP, Van Sonderen E, Alings AM, Tijssen JG, Hillege HL, Tuininga YS, Van Veldhuisen DJ, Ranchor AV, Van Gelder IC; RACE II Investigators. The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy . in Permanent Atrial Fibrillation II) study. Journal of the American College of Cardiology. 2011;58(17):1795-1803. DOI: 10.1016/j.jacc.2011.06.055
24. Kotecha D, Holmes J, Krum H, Altman DG, Manzano L, Cleland JG, Lip GY, Coats AJ, Andersson B, Kirchhof P, von Lueder TG, Wedel H, Rosano G, Shibata MC, Rigby A, Flather MD; Beta-Blockers in Heart Failure Collaborative Group. Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis. The Lancet. 2014;384(9961):2235-2243. DOI: 10.1016/S0140-6736(14)61373-8
25. Stevenson WG, Stevenson LW, Middlekauff HR, Fonarow GC, Hamilton MA, Woo MA, Saxon LA, Natterson PD, Steimle A, Walden JA, Tillisch JH. Improving survival for patients with atrial fibrillation and advanced heart failure. Journal of American College of Cardiology. 1996;28(6):1458-1463. DOI: 10.1016/s0735-1097(96)00358-0
26. Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O’Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation. 2004;109(16):1973-1980. DOI: 10.1161/01.CIR.0000118472.77237
27. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G; EAST-AFNET 4 Trial Investigators. Early rhythm-control therapy in patients with atrial fibrillation. The New England Journal of Medicine. 2020;383(14):1305-1316. DOI: 10.1056/NEJMoa2019422
28. Di Biase L, Mohanty P, Mohanty S, Santangeli P, Trivedi C, Lakkireddy D, Reddy M, Jais P, Themistoclakis S, Dello Russo A, Casella M, Pelargonio G, Narducci ML, Schweikert R, Neuzil P, Sanchez J, Horton R, Beheiry S, Hongo R, Hao S, Rossillo A, Forleo G, Tondo C, Burkhardt JD, Haissaguerre M, Natale A. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC Multicenter Randomized Trial. Circulation. 2016;133(17):1637-1644. DOI: 0.1161/CIRCULATIONAHA.115.019406
29. Hunter RJ, Berriman TJ, Diab I, Kamdar R, Richmond L, Baker V, Goromonzi F, Sawhney V, Duncan E, Page SP, Ullah W, Unsworth B, Mayet J, Dhinoja M, Earley MJ, Sporton S, Schilling RJ. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial). Circulation. Arrhythmia and Electrophysiology. 2014;7(1):31-38. DOI: 10.1161/CIRCEP.113.000806
30. Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, Merkely B, Pokushalov E, Sanders P, Proff J, Schunkert H, Christ H, Vogt J, Bänsch D; CASTLE-AF Investigators. Catheter ablation for atrial fibrillation with heart failure. The New England Journal of Medicine. 2018;378(5):417-427. DOI:10.1056/NEJMoa1707855
31. Packer DL, Mark DB, Robb RA, Monahan KH, Bahnson TD, Poole JE, Noseworthy PA, Rosenberg YD, Jeffries N, Mitchell LB, Flaker GC, Pokushalov E, Romanov A, Bunch TJ, Noelker G, Ardashev A, Revishvili A, Wilber DJ, Cappato R, Kuck KH, Hindricks G, Davies DW, Kowey PR, Naccarelli GV, Reiffel JA, Piccini JP, Silverstein AP, Al-Khalidi HR, Lee KL; CABANA Investigators. Effect of catheter ablation vs antiarrhythmic drug therapy on mortality, stroke, bleeding, and cardiac arrest among patients with atrial fibrillation: the CABANA randomized clinical trial. JAMA. 2019;321(13):1261-1274. DOI: 10.1001/jama.2019.0693
32. Packer DL, Piccini JP, Monahan KH, Al-Khalidi HR, Silverstein AP, Noseworthy PA, Poole JE, Bahnson TD, Lee KD, Mark DB; CABANA Investigators. Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial. Circulation. 2021;143(14):1377-1390. DOI: 10.1161/CIRCULATIONAHA.120.05099
33. Cirasa A, La Greca C, Pecora D, Sorgato A, Simoncelli U, Campana M, Cuccia C. Catheter ablation of atrial fibrillation in heart failure: clinical, prognostic, and echocardiographic outcome. Journal of Interventional Cardiac Electrophysiology. 2021;60(2):221-229. DOI: 10.1007/s10840-020-00727-9
34. Gaynor SL, Schuessler RB, Bailey MS, Ishii Y, Boineau JP, Gleva MJ, Cox JL, Damiano RJ Jr. Surgical treatment of atrial fibrillation: predictors of late recurrence. The Journal of Thoracic and Cardiovascular Surgery. 2005;129(1):104-111. DOI: 10.1016/j.jtcvs.2004.08.042
35. Bando K, Kobayashi J, Sasako Y, Tagusari O, Niwaya K, Kitamura S. Effect of maze procedure in patients with atrial fibrillation undergoing valve replacement. Journal of Heart Valve Disease. 2002;11(5):719-724; discussion 725. Accessed 2022 Apr 06. PMID: 12358411
36. Kik C, Bogers AJJC. Maze procedures for atrial fibrillation, from history to practice. Cardiology Research. 2011;2(5):201-207. DOI: 10.4021/cr79w
37. Моллаева Д.Д., Машина Т.В., Мрикаев Д.В., Бердибеков Б.Ш., Филатов А.Г., Голухова Е.З. Современные ультразвуковые методы оценки структурно-функциональных изменений левого предсердия у пациентов с фибрилляцией предсердий. Креативная кардиология. 2021;15(1):48-60. [Mollayeva DD, Mashina TV, Mrikayev DV, Berdibekov BSh, Filatov AG, Golukhova EZ. Modern ultrasound techniques in the assessment of left atrium structural abnormalities in patients with atrial fibrillation. Creative Cardiology. 2021;15(2):48-60 (In Russian)]. DOI: 10.24022/1997-3187-2021-15-1-48-60
38. Castellá M, Kotecha D, van Laar C, Wintgens L, Castillo Y, Kelder J, Aragon D, Nuñez M, Sandoval E, Casellas A, Mont L, van Boven WJ, Boersma LVA, van Putte BP. Thoracoscopic vs. catheter ablation for atrial fibrillation: long-term follow-up of the FAST randomized trial. Europace. 2019;21(5):746-753. DOI: 10.1093/europace/euy325
39. Haldar S, Khan HR, Boyalla V, Kralj-Hans I, Jones S, Lord J, Onyimadu O, Satishkumar A, Bahrami T, De Souza A, Clague JR, Francis DP, Hussain W, Jarman JW, Jones DG, Chen Z, Mediratta N, Hyde J, Lewis M, Mohiaddin R, Salukhe TV, Murphy C, Kelly J, Khattar RS, Toff WD, Markides V, McCready J, Gupta D, Wong T. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. European Heart Journal. 2020;41(47):4471-4480. DOI: 10.1093/eurheartj/ehaa658
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]